Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
03/12/1997 | EP0761687A1 Process for preparing antibody |
03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) |
03/12/1997 | EP0761233A2 Transkaryotic implantation |
03/12/1997 | EP0761230A2 Vaccine containing Bordetella pertussis outer membrane protein, and method of making such vaccine |
03/12/1997 | EP0761034A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
03/12/1997 | EP0760867A1 Compositions and methods relating to dna mismatch repair genes |
03/12/1997 | EP0760864A1 Dna encoding glutamate gated chloride channels |
03/12/1997 | EP0760858A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
03/12/1997 | EP0760857A1 Receptor for oncostatin m |
03/12/1997 | EP0760855A1 Hepatitis c virus asialoglycoproteins |
03/12/1997 | EP0760852A1 Immunosuppressant target proteins |
03/12/1997 | EP0760851A1 Tumor necrosis factor receptor-associated factors |
03/12/1997 | EP0760850A1 P2x RECEPTORS (PURINOCEPTOR FAMILY) |
03/12/1997 | EP0760823A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
03/12/1997 | EP0644774A4 Improved production of reproductive hormones. |
03/12/1997 | EP0627001A4 Mammalian sos - a regulator/effector of tyrosine kinase signalling. |
03/12/1997 | EP0367767B1 Bacillus thuringiensis p-2 toxin gene, protein and related insecticide compositions |
03/12/1997 | CN1145077A Immuno-stimulatory monoclonal antibodies |
03/12/1997 | CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides |
03/12/1997 | CN1144845A Fusion albumen of new human granulocyte macrophage colony stimulating factor |
03/11/1997 | US5610282 cDNA encoding a rat D1 dopamine receptor linked to adenylyl cyclase activation and expression of the receptor protein in plasmid-transfected cell lines |
03/11/1997 | US5610280 Antitumor |
03/11/1997 | US5610279 Human TNF receptor |
03/11/1997 | US5610276 Determination whether a cell is cancerous |
03/11/1997 | US5610137 Transgenic, cross-linked hemoglobin |
03/11/1997 | US5610058 Cytotrophoblast antigen and monoclonal antibodies which specifically bind cytotrophoblast cells |
03/11/1997 | US5610057 Monoclonal antibody specific for IgA receptor |
03/11/1997 | US5610035 Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies |
03/11/1997 | US5610031 B1k chain of laminin and methods of use |
03/11/1997 | US5610023 Method of purification of clostridium difficile toxin A and production of mono-specific antibodies |
03/11/1997 | US5610013 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
03/11/1997 | US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods |
03/11/1997 | US5610009 Mammalian expression systems for hepatitis C virus envelope genes |
03/11/1997 | CA1338981C Biologically active proteins and a method for their production |
03/06/1997 | WO1997008335A1 Monoclonal antibody recognizing serum amyloid a |
03/06/1997 | WO1997008334A1 Cryptophycins from aberrant biosynthesis |
03/06/1997 | WO1997008324A1 Methods for enhancing the production of interferon in cell culture |
03/06/1997 | WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
03/06/1997 | WO1997008320A1 Protein/(poly)peptide libraries |
03/06/1997 | WO1997008319A1 Genetic alterations related to familial alzheimer's disease |
03/06/1997 | WO1997008315A1 Cloning methods for high strength spider silk proteins |
03/06/1997 | WO1997008307A1 Heterologous protein production system using avian cells |
03/06/1997 | WO1997008304A2 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |
03/06/1997 | WO1997008292A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
03/06/1997 | WO1997008202A1 Antisecretory factor peptides regulating pathological permeability changes |
03/06/1997 | WO1997008201A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
03/06/1997 | WO1997008199A2 Antimicrobial cationic peptides and methods of screening for the same |
03/06/1997 | WO1997008196A1 Neurturin and related growth factors |
03/06/1997 | WO1997007798A1 Pharmaceutical compounds |
03/06/1997 | WO1997005255A3 Helper viruses for preparing recombinant viral vectors |
03/06/1997 | WO1996040929A3 Transferrin receptor genes |
03/06/1997 | CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
03/06/1997 | CA2246117A1 Cryptophycins from aberrant biosynthesis |
03/06/1997 | CA2230654A1 Genetic alterations related to familial alzheimer's disease |
03/06/1997 | CA2230540A1 Pharmaceutical compounds |
03/06/1997 | CA2230160A1 Antimicrobial cationic peptides and methods of screening for the same |
03/06/1997 | CA2230055A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
03/06/1997 | CA2229043A1 Protein/(poly)peptide libraries |
03/05/1997 | EP0760014A1 Identification and use of antiviral compounds |
03/05/1997 | EP0760000A1 Alphavirus expression vector |
03/05/1997 | EP0759998A1 Process for the lysis of a culture of lactic acid bacteria by means of a lysin, and uses of the resulting lysed culture |
03/05/1997 | EP0759989A1 IMPROVED $i(BACILLUS THURINGIENSIS) $g(d)-ENDOTOXIN |
03/05/1997 | EP0759988A1 NUCLEIC ACIDS OF $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) AND METHODS AND COMPOSITIONS FOR DIAGNOSING $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) INFECTION |
03/05/1997 | EP0759987A1 Human restrictin and nucleic acid sequences |
03/05/1997 | EP0759986A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
03/05/1997 | EP0759985A1 Transgenic arthritic mice |
03/05/1997 | EP0759984A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
03/05/1997 | EP0759982A1 Extraction of heterologous insoluble proteins from bacteria |
03/05/1997 | EP0759981A1 A method of cultivating bacteria producing proteins that are expressed in a temperature regulated manner |
03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
03/05/1997 | EP0759978A1 Neurotransmitter transporter |
03/05/1997 | EP0759977A1 AN ENZYME WITH $g(b)-(1-6)-ENDOGLUCANASE ACTIVITY |
03/05/1997 | EP0759975A1 Light-regulated promoters for production of heterologous proteins in filamentous fungi |
03/05/1997 | EP0759944A1 Improvements in or relating to peptide delivery |
03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
03/05/1997 | EP0759935A1 Recombinant papilloma virus l1 |
03/05/1997 | EP0759934A1 Neurotensin antagonist peptides |
03/05/1997 | EP0759932A1 Collagen from cell cultures |
03/05/1997 | EP0759931A1 An enzymatic process for producing a desired protein from an amino terminal extended protein |
03/05/1997 | EP0759930A1 Chimeric mhc class i antigens for inducing allograft tolerance |
03/05/1997 | EP0759777A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
03/05/1997 | EP0759762A1 Recombinant fibrin chains, fibrin and fibrin-homologs |
03/05/1997 | EP0759759A1 P75 tnf receptor promoters |
03/05/1997 | EP0759693A1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS |
03/05/1997 | EP0708877B1 Method for repairing a combustion chamber assembly |
03/05/1997 | EP0656064B1 Bispecific immunoadhesins |
03/05/1997 | EP0612349B1 Novel thrombin inhibitor protein from reduvii |
03/05/1997 | EP0584360B1 Wf11243 substance |
03/05/1997 | EP0512087B1 Process for reactivating denatured protein |
03/05/1997 | EP0498804B1 A method of preparing a vaccine or toxoid |
03/05/1997 | CN1144273A Method for preparation of polypeptide and amino-acid by enzymatic hydrolysis of animal slaughtering blood |
03/05/1997 | CN1144272A Hepatitis B surface antigen containing front surface antigen 1 and 2 immunodeterminant |
03/05/1997 | CN1144095A Ear drops for external use for promoting growth of acoustic nerve and preparation method thereof |
03/04/1997 | US5608151 Anti-microbial proteins |
03/04/1997 | US5608036 Enhanced secretion of polypeptides |
03/04/1997 | US5607919 Anti-microbial proteins |
03/04/1997 | US5607862 Assay for N-terminal type I collagen telopeptide that survives bone resorption in vivo |